Background: The family medical history is an important risk factor for several common chronic diseases but challenges remain in efficiently identifying individuals at increased risk. Family history questionnaires (FHQs) may have an important role in primary care as a screening tool to support tailored disease prevention. Aims: To systematically review studies reporting on the use and outcomes of FHQs in a clinical setting. Methods: Studies were identified through electronic searches of Medline, EMBASE, CINAHL, PsychInfo, and Google Scholar until December 2007. Due to the heterogeneity of the included papers, formal synthesis was not possible. We therefore developed a taxonomy based on the principal objectives and design of each study. Results: A plethora of FHQs were identified but few had been formally evaluated. Forty-four publications were reviewed. Sixteen papers met our inclusion criteria reporting 14 different FHQs. The majority of FHQs focused on 1 or more cancers. Twelve papers reported on the evaluation of a FHQ in a non-referred population, predominantly in primary care practice. Four papers reported a formal validation of a FHQ against a reference standard, demonstrating reasonable accuracy. Six further papers showed that a FHQ can be used to identify populations at increased risk of cancer, many of whom had not been previously identified. Two papers found a positive impact of using a FHQ on subsequent cancer screening, and a further 3 found no significant psychological long-term harm associated with their use. Conclusions: Despite the abundance of available FHQs, few have been formally evaluated. Several short single-cancer specific FHQs exist, but there are no simple, short generic FHQs suitable for use in primary care practice. FHQs can be used to obtain reasonably accurate family history information and to identify populations at increased disease risk. They have been shown to have a positive impact on cancer screening and are not associated with long-term psychological harm.

1.
Department of Health NHS. Choosing Health: Making healthy choices easier. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyandGuidance/DH_4094550 (accessed 15 October 2007).
2.
Department of Health NHS. Our health, our care, our say. http://www.dh.gov.uk/en/Healthcare/Ourhealthourcareoursay/index.htm (accessed 15 October 2007).
3.
Hawe E, Talmud P, Miller G, Humphries SE; Second Northwick Park Heart Study: Family history is a coronary heart disease risk factor in the Second Northwick Park Heart Study. Ann Hum Genet2003;67:97–106.
4.
Harrison T, Hindorff L, Kim H, Wines RC, Bowen DJ, McGrath BB, Edwards KL: Family history of diabetes as a potential public health tool. Am J Prev Med2003;24:152–159.
5.
Collaborative Group on Hormonal Factors in Breast Cancer: Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001;358:1389–1399.
6.
Johns L, Houlston R: A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001;96:2992–3003.
7.
Pharoah P, Ponder B: The genetics of ovarian cancer. Best Pract Res Clin Obstet Gynaecol 2002;16:449–468.
8.
Brandi M, Gennari L, Cerinic M, Becherini L, Falchetti A, Masi L, Gennari C, Reginster JY: Genetic markers of osteoarticular disorders: facts and hopes. Arthritis Res 2001;3:270–280.
9.
Cole Johnson C, Ownby DR, Havstad SL, Peterson EL: Family history, dust mite exposure in early childhood, and risk for pediatric atopy and asthma. J Allergy Clin Immunol 2004;114:105–110.
10.
Runeson B, Asberg M: Family history of suicide among suicide victims. Am J Psychiatry 2003;160:1525–1526.
11.
Waters I, Watson W, Wetzel W: Genograms. Can Fam Physician 1994;40:282–287.
12.
Rich E, Burke W, Heaton C, Haga S, Pinsky L, Short MP, Acheson L: Reconsidering the family history in primary care. J Gen Intern Med 2004;19:273–280.
13.
Acheson LS, Zyzanski SJ, Stange KC, Deptowicz A, Wiesner GL: Validation of a self-administered, computerized tool for collecting and displaying the family history of cancer. J Clin Oncol 2006;24:5395–5402.
14.
Alberto V, Harocopos C, Patel A, Clark SK: Family and personal history in colorectal cancer patients: what are we missing?Colorectal Dis 2006;8:612–614.
15.
Bensen J, Liese A, Rushing J, Province M, Folsom AR, Rich SS, Higgins M: Accuracy of proband reported family history: the NHLBI Family Heart Study (FHS). Genet Epidemiol 1999;17:141–150.
16.
Brener D, Schulz C, Schluger A, Offit K: A self-administered family history questionnaire (FHQ) utilized in an outpatient setting to assess cancer risk. Am J Hum Genet 1996;59:A333.
17.
Cherry C: Using family history to assess women’s cancer risk in a parish nurse setting. Nurs Health Sci 2006;8:129.
18.
Church J, McGannon E: Family history of colorectal cancer – How often and how accurately is it recorded? Dis Colon Rectum 2000;43:1540–1544.
19.
Colditz G, Atwood K, Emmons K, Monson RR, Willett WC, Trichopoulos D, Hunter DJ: Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention. Cancer Causes Control 2000;11:477–488.
20.
Cole J, Conneally P, Hodes M, Merritt AD: Genetic family history questionnaire. J Med Genet 1978;15:10–18.
21.
de Bock GH, Vliet Vlieland TP, Hageman GC, Oosterwijk JC, Springer MP, Kievit J: The assessment of genetic risk of breast cancer: a set of GP guidelines. Fam Pract 1999;16:71–77.
22.
Emmons K, Koch-Weser S, Atwood K, Conboy L, Rudd R, Colditz G: A qualitative evaluation of the Harvard Cancer Risk Index. J Health Commun 1999;4:181–193.
23.
Emmons K, Wong M, Puleo E, Weinstein N, Fletcher R, Colditz G: Tailored computer-based cancer risk communication: correcting colorectal cancer risk perception.J Health Commun 2004;9:127–141.
24.
Fisher T, Kirk J, Hopper J, Godding R, Burgemeister FC: A simple tool for identifying unaffected women at a moderately increased or potentially high risk of breast cancer based on their family history. Breast 2003;12:120–127.
25.
Fletcher R, Lobb R, Bauer M, Kemp JA, Palmer RC, Kleinman KP, Miroshnik I, Emmons KM: Screening patients with a family history of colorectal cancer. J Gen Intern Med 2007;22:508–513.
26.
Frezzo T, Rubinstein W, Dunham D, Ormond KE: The genetic family history in internal medicine as a risk assessment tool. Genet Med 2003;5:84–91.
27.
Gilpin C, Carson N, Hunter A: A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center. Clin Genet 2000;58:299–308.
28.
Glanz K, Schoenfeld E, Weinstock M, Layi G, Kidd J, Shigaki DM: Development and reliability of a brief skin cancer risk assessment tool. Cancer Detect Prev 2003;27:311–315.
29.
Grover S, Stoffel E, Bussone L, Tschoegl E, Syngal S: Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol 2004;2:813–819.
30.
Hampel H, Sweet K, Westman J, Offit K, Eng C: Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 2004;41:81–91.
31.
Hariri S, Yoon P, Qureshi N, Valdez R, Scheuner MT, Khoury MJ: Family history of type 2 diabetes: a population-based screening tool for prevention? Genet Med 2006;8:102–108.
32.
Higgins M, Province M, Heiss G, Eckfeldt J, Ellison RC, Folsom AR, Rao DC, Sprafka JM, Williams R: NHLBI family heart study: objectives and design. Am J Epidemiol 1996;143:1219–1228.
33.
House W, Sharp D, Sheridan E: Identifying and screening patients at high risk of colorectal cancer in general practice. J Med Screen 1999;6:205–208.
34.
Hughes KS, Roche C, Campbell CT, Siegel N, Salisbury L, Chekos A, Katz MS, Edell E: Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire. Breast J 2003;9:19–25.
35.
Hunt K, Emslie C, Watt G: Lay constructions of a family history of heart disease: potential for misunderstandings in the clinical encounter? Lancet 2001;357:1168–1171.
36.
Hunt S, Williams R, Barlow G: A comparison of positive family history definitions for defining risk of future disease. J Chron Dis 1986;39:809–821.
37.
Johnson J, Giles R, Larsen L, Ware J, Adams T, Hunt SC: Utah’s family high risk program: bridging the gap between genomics and public health. Prev Chronic Dis 2005;2:A24.
38.
Johnson N, Lancaster T, Fuller A, Hodgson SV: The prevalence of a family history of cancer in general practice. Fam Pract 1995;12:287–289.
39.
Kadison P, Pelletier E, Mounib E, Oppedisano P, Poteat HT: Improved screening for breast cancer associated with a telephone-based risk assessment. Prev Med 1998;27:493–501.
40.
Kelly K, Sweet K: In search of a familial cancer risk assessment tool. Clin Genet 2007;71:76–83.
41.
Leggatt V, Mackay J, Marteau T, Yates JR: The psychological impact of a cancer family history questionnaire completed in general practice. J Med Genet 2000;37:470–472.
42.
Leggatt V, Mackay J, Yates J: Evaluation of questionnaire on cancer family history in identifying patients at increased genetic risk in general practice. Br Med J 1999;319:757–758.
43.
McCusker M, Yoon P, Gwinn M, Malarcher AM, Neff L, Khoury MJ: Family history of heart disease and cardiovascular disease risk-reducing behaviors. Genet Med 2004;6:153–158.
44.
Mussio P, Weber W, Brunetti D, Stemmermann GN, Torhorst J: Taking a family history in cancer patients with a simple questionnaire. Anticancer Res 1998;18:2811–2814.
45.
Qureshi N, Bethea J, Modell B, Brennan P, Papageorgiou A, Raeburn S, Hapgood R, Modell M: Collecting genetic information in primary care: evaluating a new family history tool. Fam Pract 2005;22:663–669.
46.
Qureshi N, Standen P, Hapgood R, Hayes J: A randomized controlled trial to assess the psychological impact of a family history screening questionnaire in general practice. Fam Pract 2001;18:78–83.
47.
Rose P, Murphy M, Munafo M, Chapman C, Mortensen N, Lucassen A: Improving the ascertainment of families at high risk of colorectal cancer: a prospective GP register study. Br J Gen Pract 2004;54:267–271.
48.
Scheuner MT, Wang SJ, Raffel LJ, Larabell SK, Rotter JI: Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am J Med Genet 1997;71:315–324.
49.
Schroy PC 3rd, Glick JT, Geller AC, Jackson A, Heeren T, Prout M: A novel educational strategy to enhance internal medicine residents’ familial colorectal cancer knowledge and risk assessment skills. Am J Gastroenterol 2005;100:677–684.
50.
Sweet KM, Bradley T, Westman J: Identification and referral of families at high risk for cancer susceptibility. J Clin Oncol 2002;20:528–537.
51.
Wallace E, Hinds A, Campbell H, Mackay J, Cetnarskyj R, Porteous ME: A cross-sectional survey to estimate the prevalence of family history of colorectal, breast and ovarian cancer in a Scottish general practice population. Br J Cancer 2004;91:1575–1579.
52.
Warner E, Heisey R, Goel V, Carroll JC, McCready DR: Hereditary breast cancer – risk assessment of patients with a family history of breast cancer. Can Fam Physician 1999;45:104–112.
53.
Watt G, McConnachie A, Upton M, Emslie C, Hunt K: How accurately do adult sons and daughters report and perceive parental deaths from coronary disease? J Epidemiol Community Health 2000;54:859–863.
54.
Westman J, Hampel H, Bradley T: Efficacy of a touchscreen computer based family cancer history questionnaire and subsequent cancer risk assessment. J Med Genet 2000;37:354–360.
55.
Williams R, Hunt S, Barlow G, Chamberlain RM, Weinberg AD, Cooper HP, Carbonari JP, Gotto AM Jr: Health family trees – a tool for finding and helping young family members of coronary and cancer prone pedigrees in Texas and Utah. Am J Public Health 1988;78:1283–1286.
56.
Williams R, Hunt S, Heiss G, Province MA, Bensen JT, Higgins M, Chamberlain RM, Ware J, Hopkins PN: Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (The Health Family Tree Study and the NHLBI Family Heart Study). Am J Cardiol 2001;87:129–135.
57.
Qureshi N, Wilson B, Santaguida P, Carroll J, Allanson J, Culebro CR, Brouwers M, Raina P: Collection and use of cancer family history in primary care. Evid Rep Technol Assess (Full Rep) 2007;159:1–84.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.